Table 4.
Intensive care unit admission, management, and outcome of patients infected with severe acute respiratory syndrome coronavirus-2 as well as distribution according to symptoms
| Category | Level | All, n (%) | Symptomatic (n=913), n (%) | Asymptomatic (n=138), n (%) | P |
|---|---|---|---|---|---|
| Medication | Antibiotic | 596 (73.9) | 566 (78.6) | 30 (34.5) | <0.0001 |
| Hydroxychloroquine | 258 (32.0) | 250 (34.7) | 8 (9.2) | <0.0001 | |
| Steroid | 94 (14.8) | 92 (14.8) | 2 (2.5) | 0.001 | |
| Oseltamivir | 130 (20.5) | 117 (21.1) | 13 (16.5) | 0.34 | |
| ICU admission | 115 (11.3) | 107 (12.1) | 8 (6.0) | 0.04 | |
| Hospital length of stay (days)* | 0-1 | 82 (10.2) | 73 (10.4) | 9 (8.7) | 0.19 |
| 2-7 | 423 (52.5) | 362 (51.6) | 61 (58.7) | ||
| 8-14 | 216 (26.8) | 187 (26.7) | 29 (27.9) | ||
| >14 | 84 (10.4) | 79 (11.3) | 5 (4.8) | ||
| Outcome | Remained admitted at the time of data collection | 240 (22.8) | 207 (22.7) | 33 (23.9) | 0.78 |
| Discharged | 770 (73.3) | 669 (73.3) | 101 (73.2) | ||
| Died | 41 (3.9) | 37 (4.1) | 4 (2.9) |
*Among discharged patients. ICU – Intensive care unit